301 results on '"TABAK, Fehmi"'
Search Results
2. Safety of SARS-CoV-2 vaccination in patients with Behcet’s syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine
3. Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial
4. Clinical outcomes of geriatric patients with COVID-19: review of one-year data
5. Resistance Genes and Mortality in Carbapenem-resistant Klebsiella pneumoniae Bacteremias: Effects of the COVID-19 Pandemic.
6. The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome
7. Tocilizumab in COVID-19: The Cerrahpaşa-PREDICT score
8. Colistin resistance increases 28-day mortality in bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae
9. Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey
10. Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly
11. Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey
12. Change in species distribution and antifungal susceptibility of candidemias in an intensive care unit of a university hospital (10-year experience)
13. Urinary tract infections in older adults: associated factors for extended-spectrum beta-lactamase production.
14. An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital
15. Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
16. Reactivation of Hepatitis B Virus Following Treatment of Hepatitis C Virus Infection in Coinfected Patients
17. Evaluation of Empirical and Preemptive Therapy Approaches of Invasive Mold Infections in Patients with Hematologic Malignancy.
18. Investigation of the Prevalence of HBsAg, Anti-HCV, and Anti-HIV in a Prison in Turkey: A Point Prevalence Study.
19. Discontinuation of Nucleos(t)ide Analog treatment in HBeAg-Negative Non-Cirrhotic Chronic Hepatitis B Patients: Real-Life Data of 20 Years.
20. Diagnostic value of F-18 FDG PET/CT in patients with spondylodiscitis: Is dual time point imaging time worthy?
21. Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome
22. Flow Cytometric Analysis of Lymphocyte Subsets of Covid-19 Patients from A Single Centre in Turkey.
23. Performance of noninvasive fibrosis indices in chronic hepatitis B during pretreatment and post-treatment periods.
24. Increase in transaminase levels during COVID-19 infection and its association with poor prognosis.
25. Factors Influencing HIV Infection in Children Born to HIV-Infected Mothers in Turkey.
26. Bağışıklığı Baskılanmış Hastalarda COVID-19 İnfeksiyonuna Bağlı Morbidite ve Mortalite: Hangi Faktörler Etkili?
27. HIV/AIDS Kongresi 2022'nin Ardından: Türkiye'de HIV İnfeksiyonu ile Mücadelede Kazanımlar, Zorluklar ve Öneriler.
28. Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review.
29. Epidemiology of HBV subgenotypes D
30. The changing epidemiology of delta hepatitis in Türkiye over three decades: A systematic review.
31. Modeling the future of HIV in Turkey: Cost-effectiveness analysis of improving testing and diagnosis.
32. Efficacy of tigecycline and vancomycin in experimental catheter-related Staphylococcus epidermidis infection: microbiological and electron microscopic analysis of biofilm
33. The Effect of the Administration of Interferon and Steroids on Regulatory T-cells in the Liver, Spleen, and Bone Marrow of Mice.
34. Adding Pegylated Interferon to Entecavir for Hepatitis B e Antigen–Positive Chronic Hepatitis B: a Multicenter Randomized Trial (ARES Study)
35. Incidence, Risk Factors, and Prognosis of Bloodstream Infections in COVID-19 Patients in Intensive Care: A Single-Center Observational Study.
36. Eliminating Viral Hepatitis in Turkey: Achievements and Challenges.
37. A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection
38. Vertebral osteomyelitis: eight years’ experience of 100 cases
39. Long-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B Infection
40. Clinicopathologic features of dual chronic hepatitis B and C infection: A comparison with single hepatitis B, C and delta infections
41. Ganciclovir-resistant cytomegalovirus encephalitis in a hematopoietic stem cell transplant recipient
42. Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis delta
43. Epidemiological Profile of Naïve HIV-1/AIDS Patients in Istanbul: The Largest Case Series from Turkey§
44. Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta
45. Efficacy of Pre-S-containing HBV Vaccine Combined with Lamivudine in the Treatment of Chronic HBV Infection
46. Correlation of Quantitative Assay of HBsAg and HBV DNA Levels During Chronic HBV Treatment
47. Remdesivir treatment for patients with moderate to severe COVID-19.
48. Human immunodeficiency virus type 1 impairs sumoylation.
49. A pan-resistant Myroides odoratimimus catheter-related bacteremia in a COVID-19 patient and review of the literature.
50. Withdrawal of Staphylococcus aureus from intensive care units in Turkey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.